Gene · 4085
Papers3,516
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,516
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods. | Front Genet | 2021 | 33767726 | PubTator, text mining | PubMed |
| FBXO6-mediated RNASET2 ubiquitination and degradation governs the development of ovarian cancer. | Cell Death Dis | 2021 | 33767133 | PubTator, text mining | PubMed |
| A gene module identification algorithm and its applications to identify gene modules and key genes of hepatocellular carcinoma. | Sci Rep | 2021 | 33750838 | PubTator, text mining | PubMed |
| Role of Lipid Metabolism and Signaling in Mammalian Oocyte Maturation, Quality, and Acquisition of Competence. | Front Cell Dev Biol | 2021 | 33748128 | PubTator, text mining | PubMed |
| Expression of cyclin-dependent kinases and their clinical significance with immune infiltrates could predict prognosis in colorectal cancer. | Biotechnol Rep (Amst) | 2021 | 33732631 | PubTator, text mining | PubMed |
| A Transcriptomic Signature for Risk-Stratification and Recurrence Prediction in Intrahepatic Cholangiocarcinoma. | Hepatology | 2021 | 33725402 | PubTator, text mining | PubMed |
| Aerobic glycolysis supports hepatitis B virus protein synthesis through interaction between viral surface antigen and pyruvate kinase isoform M2. | PLoS Pathog | 2021 | 33720996 | PubTator, text mining | PubMed |
| Integrated Protein-Protein Interaction and Weighted Gene Co-expression Network Analysis Uncover Three Key Genes in Hepatoblastoma. | Front Cell Dev Biol | 2021 | 33718368 | PubTator, text mining | PubMed |
| Bub1 kinase in the regulation of mitosis. | Anim Cells Syst (Seoul) | 2021 | 33717411 | PubTator, text mining | PubMed |
| Unbiased proteomic profiling of host cell extracellular vesicle composition and dynamics upon HIV-1 infection. | EMBO J | 2021 | 33709510 | PubTator, text mining | PubMed |
| Emerging Role of MiR-192-5p in Human Diseases. | Front Pharmacol | 2021 | 33708127 | PubTator, text mining | PubMed |
| Potential role of glucosamine-phosphate N-acetyltransferase 1 in the development of lung adenocarcinoma. | Aging (Albany NY) | 2021 | 33686019 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Caco-2 Cells upon the Exposure of Mycotoxin Deoxynivalenol and Its Acetylated Derivatives. | Toxins (Basel) | 2021 | 33671637 | PubTator, text mining | PubMed |
| Prognostic Gene Expression, Stemness and Immune Microenvironment in Pediatric Tumors. | Cancers (Basel) | 2021 | 33670534 | PubTator, text mining | PubMed |
| Identification of the hub gene BUB1B in hepatocellular carcinoma via bioinformatic analysis and in vitro experiments. | PeerJ | 2021 | 33665036 | PubTator, text mining | PubMed |
| Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. | Arch Toxicol | 2021 | 33660061 | PubTator, text mining | PubMed |
| Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma. | Cancer Cell Int | 2021 | 33653340 | PubTator, text mining | PubMed |
| HuR up-regulates cell surface PD-L1 via stabilizing CMTM6 transcript in cancer. | Oncogene | 2021 | 33649535 | PubTator, text mining | PubMed |
| Evidence that polyploidy in esophageal adenocarcinoma originates from mitotic slippage caused by defective chromosome attachments. | Cell Death Differ | 2021 | 33649470 | PubTator, text mining | PubMed |
| Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma. | BMC Cancer | 2021 | 33648465 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4085/papers?page=45